Please assess the completion status of the following clinical trial:

Trial Title: Insulin Analogues and Severe Hypoglycaemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Type 1 diabetes for 5 years.~* Age\>18 years.~* Two or more episodes of hypoglycaemia during the last year,~Exclusion Criteria:~* History of Addisons disease~* Growth hormone deficiency or untreated myxoedema~* CVD within 6 months~* Cancer within 5 years~* Alcohol or drug abuse~* Pregnant or lactating women~* Fertile women without effective contraception~* Participation in another trial within 30 days~* Inability to understand the informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): HUman Insulin
- 2 (Type: EXPERIMENTAL): Analogue insulin

Based on this trial design, predict the completion outcome and termination type (if applicable).